<DOC>
	<DOCNO>NCT02398136</DOCNO>
	<brief_summary>The purpose study see whether ketamine , give repeatedly via nose ( intranasally ) , produce quick persistent improvement PTSD symptom . At high dos , ketamine use many year anesthetic medical procedure , low dos may effective treatment patient major depression PTSD .</brief_summary>
	<brief_title>To Test Potential Efficacy Repeated Intranasal Administration Ketamine Treatment PTSD</brief_title>
	<detailed_description>The objective present research protocol , parallel-arm , double-blind , randomize control clinical trial , test efficacy repeat intranasal administration glutamatergic NMDA receptor antagonist ketamine providing ( 1 ) rapid relief ( 2 ) sustain improvement core PTSD symptoms co-morbid depressive symptom patient chronic PTSD . The effect ketamine compare repeat intranasal administration benzodiazepine anesthetic midazolam , mimic acute subjective effect ketamine expect less less sustained anxiolytic effect , sustain antidepressant effect .</detailed_description>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Men woman , 1865 year age ; Participants must level understanding sufficient agree test examination require protocol must sign write informed consent document ; Participants must fulfill DSM5 criterion current civilian combatrelated PTSD , base clinical assessment study psychiatrist CAPS do ensure least moderate severity safeguard high placebo response rate ; Women must use medically accept reliable mean contraception ( use oral contraceptive medication , must also use barrier contraceptive ) childbearing potential ( i.e. , surgically sterile , postmenopausal least one year ) ; Women childbearing potential must negative pregnancy test screen prior intranasal administration ; Participants must able identify family member , physician , friend ( i.e . someone know well ) participate Treatment Contract ( e.g . contact study physician behalf case manic symptom suicidal thought develop ) . Women plan become pregnant , pregnant breastfeeding ( medical risk use ketamine pregnancy breastfeed unknown ) ; Serious , unstable medical illness hepatic , renal , gastroenterologic , respiratory , cardiovascular , endocrinologic , neurologic , immunologic , hematologic disease , include gastroesophageal reflux disease , obstructive sleep apnea , history difficulty airway management previous anesthetic , ischemic heart disease uncontrolled hypertension , history severe head injury ; Clinically significant abnormal finding laboratory parameter , physical examination , ECG ; Patients uncorrected hypothyroidism hyperthyroidism ; Hormonal treatment ( e.g. , estrogen ) start 3 month prior first intranasal administration day ; Use evidencebased individual psychotherapy ( prolonged exposure ) study ; History autism , mental retardation , pervasive developmental disorder , Tourette 's syndrome ; History one seizures without clear resolve etiology ; History ( hypo ) mania ; Past current presence psychotic symptom , diagnosis lifetime psychotic disorder include schizophrenia schizoaffective disorder ; Drug alcohol abuse dependence within precede 3 month ; rather narrow time period chosen , however , order allow participation individual history substance abuse dependence problem could secondary PTSD , closely approximate patient see realworld setting ; period time use recently complete study IV ketamine PTSD . Previous recreational use ketamine PCP ; Current diagnosis bulimia nervosa anorexia nervosa ; Diagnosis schizotypal antisocial personality disorder ( since know reduce possibility study completion ) ; Axis II diagnose allow ; Patients judge clinically serious imminent suicidal homicidal risk . A blood pressure one reading 160/90 two separate reading 140/90 screen baseline visit Patients report current treatment benzodiazepine , opioid medication , mood stabilizer ( valproic acid lithium ) within 2 week prior randomization ; patient take stable dos antidepressant medication 3 month prior randomization allow . For subject may participate MRI portion study , claustrophobia , trauma surgery may leave magnetic material body , magnetic implant pacemaker , inability lie still 1 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>intervention</keyword>
	<keyword>ketamine</keyword>
	<keyword>PTSD</keyword>
	<keyword>treatment</keyword>
	<keyword>posttraumatic stress disorder</keyword>
</DOC>